why does nobody talk about shortage list
Quick one. Canada here.
state board works very differently where I live than in the threads that dominate the front page, and I keep seeing people confidently given advice that simply does not apply outside the US.
Specifics: the route I used took 2 weeks and cost roughly what I expected. The admin was worse than the cost. The thing that would have saved me the most time was knowing which document to ask for at the start.
Happy to answer questions from anyone in the same jurisdiction.
best — the order this archive was captured in
Flair changed to match the content. Read the sidebar before posting next time and we are square.
Yeah, 503A and 503B are different regulatory animals.
[removed by moderator]
Strongly agree. API source transparency matters.
The telehealth + compounding combo cost API source plus 7% markup. Not cheap but covered by insurance depending on state.
This is correct. The shortage list does expire and the rules change.
Yeah, 503A and 503B are different regulatory animals.
Asked 19 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
The confident tone is doing a lot of work that the evidence is not.
the shortage list is temporary, it ends and compounding becomes illegal again
The confident tone is doing a lot of work that the evidence is not.
Yes, exactly this, and it is the bit that took me 88 weeks to accept.
You have restated the marketing copy. What is the actual substance here.
API transparency is the question that separates good compounders from sketchy ones
the 503A/503B distinction is load-bearing, do not blur it
Respectfully this is a sample of one presented as a finding.
Respectfully this is a sample of one presented as a finding.
Adding to this: compounding is doing more work than the comment implies.
shortage list status is state board, check the actual list
no pharmacy referral codes, naming is fine, recruiting is not
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
Strongly agree. API source transparency matters.
Not to be pedantic but shortage list and 503A are being used interchangeably and they are not interchangeable in real life.
The 503A pharmacy I used lost their shortage list eligibility. Same day, compounding became illegal. Rules are real.
This is correct. The shortage list does expire and the rules change.
What is the actual shortage list status right now?
the the UK situation is different from the US, different regulations
API transparency is the question that separates good compounders from sketchy ones
no pharmacy referral codes, naming is fine, recruiting is not
- 1Asked 19 compounders about API source. One told me, one dodged, one said…12 comments in this branch · started by u/marit_mwangi
- 2Strongly agree. API source transparency matters.8 comments in this branch · started by u/santiago_rasmussen